❤️Conditions & CareFDA Mandates GLP-1 Warning Following Rare Vision Loss Reports
The FDA has introduced new label warnings for GLP-1 medications regarding a rare form of vision loss, leaving patients and physicians to weigh the benefits of treatment a…

